Literature DB >> 18698092

Regulation of the human thromboxane A2 receptor gene by Sp1, Egr1, NF-E2, GATA-1, and Ets-1 in megakaryocytes.

AnneMarie M Gannon1, B Therese Kinsella.   

Abstract

The alpha and beta isoforms of the human thromboxane A(2) (TXA(2)) receptor (TP) are encoded by a single gene but are transcriptionally regulated by distinct promoters, termed promoter 1 (Prm1) and Prm3, respectively. Herein, it was sought to identify factors regulating Prm1 within the megakaryocytic human erythroleukemia 92.1.7 cell line. Through gene deletion and reporter assays, the core Prm1 was localized to between nucleotides -6,320 and -5,895, proximal to the transcription initiation site. Furthermore, two upstream repressor and two upstream activator regions were identified. Site-directed mutagenesis of four overlapping Sp1/Egr1 elements and an NF-E2/AP1 element within the proximal region substantially reduced Prm1 activity. Deletion/mutation of GATA and Ets elements disrupted the upstream activator sequence located between -7,962 and -7,717, significantly impairing Prm1 activity. Electrophoretic mobility shift assays and chromatin immunoprecipitations confirmed that Sp1, Egr1, and NF-E2 bind to elements within the core promoter, whereas GATA-1 and Ets-1 factors bind to the upstream activator sequence (between -7,962 and -7,717). Collectively, these data establish that Sp1, Egr1, and NF-E2 regulate core Prm1 activity in the megakaryocytic-platelet progenitor cells, whereas GATA-1 and Ets-1 act as critical upstream activators, hence providing the first genetic basis for the expression of the human TXA(2) receptor (TP) within the vasculature.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18698092     DOI: 10.1194/jlr.M800256-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  6 in total

1.  Identification of an interaction between the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor with protein kinase C-related kinase (PRK) 1: implications for prostate cancer.

Authors:  Elizebeth C Turner; David J Kavanagh; Eamon P Mulvaney; Caitriona McLean; Katarina Wikström; Helen M Reid; B Therese Kinsella
Journal:  J Biol Chem       Date:  2011-02-28       Impact factor: 5.157

2.  Intermolecular cross-talk between the prostaglandin E2 receptor (EP)3 of subtype and thromboxane A(2) receptor signalling in human erythroleukaemic cells.

Authors:  Helen M Reid; B Therese Kinsella
Journal:  Br J Pharmacol       Date:  2009-08-20       Impact factor: 8.739

3.  Protein kinase C-related kinase 1 and 2 play an essential role in thromboxane-mediated neoplastic responses in prostate cancer.

Authors:  Aine G O'Sullivan; Eamon P Mulvaney; Paula B Hyland; B Therese Kinsella
Journal:  Oncotarget       Date:  2015-09-22

Review 4.  The Role and Regulation of Thromboxane A2 Signaling in Cancer-Trojan Horses and Misdirection.

Authors:  Anthony W Ashton; Yunjia Zhang; Rosanna Cazzolli; Kenneth V Honn
Journal:  Molecules       Date:  2022-09-22       Impact factor: 4.927

5.  The Wilms' tumour suppressor protein WT1 acts as a key transcriptional repressor of the human thromboxane A2 receptor gene in megakaryocytes.

Authors:  AnneMarie M Gannon; B Therese Kinsella
Journal:  J Cell Mol Med       Date:  2009 Nov-Dec       Impact factor: 5.310

6.  Expression of the TPα and TPβ isoforms of the thromboxane prostanoid receptor (TP) in prostate cancer: clinical significance and diagnostic potential.

Authors:  Eamon P Mulvaney; Christine Shilling; Sarah B Eivers; Antoinette S Perry; Anders Bjartell; Elaine W Kay; R William Watson; B Therese Kinsella
Journal:  Oncotarget       Date:  2016-11-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.